Publication | Open Access
Targeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint Therapy
67
Citations
30
References
2022
Year
Inhibition of Plk1 induces upregulation of PD-L1 expression in pancreatic ductal adenocarcinoma, stimulating antitumor immunity and sensitizing tumors to immunotherapy.
| Year | Citations | |
|---|---|---|
2021 | 42K | |
1984 | 30.3K | |
1993 | 29.8K | |
2015 | 25K | |
2007 | 17.5K | |
2021 | 17.1K | |
2014 | 5.2K | |
1993 | 3.7K | |
2019 | 2K | |
1998 | 1.5K |
Page 1
Page 1